Literature DB >> 22609912

Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Leticia V Bentancor1, Ana Camacho-Peiro, Cagla Bozkurt-Guzel, Gerald B Pier, Tomás Maira-Litrán.   

Abstract

Acinetobacter baumannii has recently emerged as a highly troublesome nosocomial pathogen, especially in patients in intensive care units and in those undergoing mechanical ventilation. We have identified a surface protein adhesin of A. baumannii, designated the Acinetobacter trimeric autotransporter (Ata), that contains all of the typical features of trimeric autotransporters (TA), including a long signal peptide followed by an N-terminal, surface-exposed passenger domain and a C-terminal domain encoding 4 β-strands. To demonstrate that Ata encoded a TA, we created a fusion protein in which we replaced the entire passenger domain of Ata with the epitope tag V5, which can be tracked with specific monoclonal antibodies, and demonstrated that the C-terminal 101 amino acids of Ata were capable of exporting the heterologous V5 tag to the surface of A. baumannii in a trimeric form. We found that Ata played a role in biofilm formation and bound to various extracellular matrix/basal membrane (ECM/BM) components, including collagen types I, III, IV, and V and laminin. Moreover, Ata mediated the adhesion of whole A. baumannii cells to immobilized collagen type IV and played a role in the survival of A. baumannii in a lethal model of systemic infection in immunocompetent mice. Taken together, these results reveal that Ata is a TA of A. baumannii involved in virulence, including biofilm formation, binding to ECM/BM proteins, mediating the adhesion of A. baumannii cells to collagen type IV, and contributing to the survival of A. baumannii in a mouse model of lethal infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609912      PMCID: PMC3416510          DOI: 10.1128/JB.06769-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  77 in total

1.  Functional mapping of the Yersinia enterocolitica adhesin YadA. Identification Of eight NSVAIG - S motifs in the amino-terminal half of the protein involved in collagen binding.

Authors:  Y E Tahir; P Kuusela; M Skurnik
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

Review 2.  Autotransporter passenger proteins: virulence factors with common structural themes.

Authors:  Kaoru Nishimura; Nami Tajima; Young-Ho Yoon; Sam-Yong Park; Jeremy R H Tame
Journal:  J Mol Med (Berl)       Date:  2010-03-09       Impact factor: 4.599

3.  Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.

Authors:  M J Rodríguez-Hernández; J Pachón; C Pichardo; L Cuberos; J Ibáñez-Martínez; A García-Curiel; F J Caballero; I Moreno; M E Jiménez-Mejías
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

4.  Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis.

Authors:  Anna C Jacobs; Indriati Hood; Kelli L Boyd; Patrick D Olson; John M Morrison; Steven Carson; Khalid Sayood; Peter C Iwen; Eric P Skaar; Paul M Dunman
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

5.  Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans.

Authors:  Davide Serruto; Tiziana Spadafina; Laura Ciucchi; Lisa A Lewis; Sanjay Ram; Marta Tontini; Laura Santini; Alessia Biolchi; Kate L Seib; Marzia M Giuliani; John J Donnelly; Francesco Berti; Silvana Savino; Maria Scarselli; Paolo Costantino; J Simon Kroll; Clíona O'Dwyer; Jiazhou Qiu; Andrew G Plaut; Richard Moxon; Rino Rappuoli; Mariagrazia Pizza; Beatrice Aricò
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

6.  Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.

Authors:  T-N Jang; S-H Lee; C-H Huang; C-L Lee; W-Y Chen
Journal:  J Hosp Infect       Date:  2009-08-27       Impact factor: 3.926

7.  Allelic Variation within Helicobacter pylori babA and babB.

Authors:  D T Pride; R J Meinersmann; M J Blaser
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

8.  Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.

Authors:  Ebbing Lautenbach; Marie Synnestvedt; Mark G Weiner; Warren B Bilker; Lien Vo; Jeff Schein; Myoung Kim
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

9.  Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.

Authors:  Suzanne F Beavers; David B Blossom; Timothy L Wiemken; Kelly Y Kawaoka; Andrew Wong; Linda Goss; Malkanthie I McCormick; Douglas Thoroughman; Arjun Srinivasan
Journal:  Public Health Rep       Date:  2009 Nov-Dec       Impact factor: 2.792

10.  Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients.

Authors:  Anselmo Caricato; Luca Montini; Giuseppe Bello; Vincenzo Michetti; Riccardo Maviglia; Maria G Bocci; Giovanna Mercurio; Salvatore M Maggiore; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

View more
  47 in total

Review 1.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

2.  The influence of two-partner secretion systems on the virulence of Acinetobacter baumannii.

Authors:  Sarah Bigot; Suzana P Salcedo
Journal:  Virulence       Date:  2017-01-24       Impact factor: 5.882

Review 3.  The Secrets of Acinetobacter Secretion.

Authors:  Brent S Weber; Rachel L Kinsella; Christian M Harding; Mario F Feldman
Journal:  Trends Microbiol       Date:  2017-02-16       Impact factor: 17.079

4.  The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain.

Authors:  A Pérez; M Merino; S Rumbo-Feal; L Álvarez-Fraga; J A Vallejo; A Beceiro; E J Ohneck; J Mateos; P Fernández-Puente; L A Actis; M Poza; G Bou
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

5.  Simple Method for Markerless Gene Deletion in Multidrug-Resistant Acinetobacter baumannii.

Authors:  Man Hwan Oh; Je Chul Lee; Jungmin Kim; Chul Hee Choi; Kyudong Han
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

6.  Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.

Authors:  Leticia V Bentancor; Abhisek Routray; Cagla Bozkurt-Guzel; Ana Camacho-Peiro; Gerald B Pier; Tomás Maira-Litrán
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

7.  Analysis of Endothelial Adherence of Bartonella henselae and Acinetobacter baumannii Using a Dynamic Human Ex Vivo Infection Model.

Authors:  Marko Weidensdorfer; Ju Ik Chae; Celestine Makobe; Julia Stahl; Beate Averhoff; Volker Müller; Christoph Schürmann; Ralf P Brandes; Gottfried Wilharm; Wibke Ballhorn; Sara Christ; Dirk Linke; Doris Fischer; Stephan Göttig; Volkhard A J Kempf
Journal:  Infect Immun       Date:  2015-12-28       Impact factor: 3.441

Review 8.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

9.  Intraspecies Transfer of the Chromosomal Acinetobacter baumannii blaNDM-1 Carbapenemase Gene.

Authors:  Thomas Krahn; Daniel Wibberg; Irena Maus; Anika Winkler; Séverine Bontron; Alexander Sczyrba; Patrice Nordmann; Alfred Pühler; Laurent Poirel; Andreas Schlüter
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

10.  Functional characterization of Burkholderia pseudomallei trimeric autotransporters.

Authors:  Cristine G Campos; Matthew S Byrd; Peggy A Cotter
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.